ArticleJournal of inflammation research2026
Persistent Airway Uric Acid is Associated with Epithelial Stress Signaling and Macrophage Inflammatory Activation in COPD.
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Uric acid has been widely studied as a systemic biomarker in pulmonary diseases; however, serum levels are strongly influenced by medication and systemic metabolic status. Whether airway-localized uric acid contributes to epithelial dysfunction in chronic obstructive pulmonary disease (COPD) remains unclear. This study investigated the relationship between persistent mucosal uric acid and epithelial stress signaling, barrier-associated alterations, and macrophage inflammatory activation during acute exacerbations of COPD. Methods: Paired serum and induced sputum samples were collected from 192 patients with acute exacerbation of COPD (AECOPD) and 194 patients with community-acquired pneumonia (CAP) at baseline and 14 days after therapy. Uric acid concentrations were measured longitudinally. BEAS-2B airway epithelial cells were exposed to uric acid concentrations (200 μg/mL), a concentration corresponding to levels observed in AECOPD sputum. RNA sequencing was performed using three biological replicates per group, followed by Ingenuity Pathway Analysis. Key translational regulators and epithelial barrier-associated proteins were validated by qPCR and Western blotting. Epithelial-macrophage interaction was evaluated using a Transwell co-culture system with cytokine quantification by ELISA. Results: Sputum uric acid was significantly higher in AECOPD (median 120.6 μmol/L) compared with CAP controls and remained elevated after therapy, despite normalization of serum uric acid. In BEAS-2B cells, uric acid exposure induced inflammatory cytokine expression without detectable cytotoxicity. Canonical NF-κB and inflammasome activation were not observed. Transcriptomic analysis identified 2,092 differentially expressed genes and revealed suppression of EIF2 signaling and GCN2-mediated amino acid sensing, indicating activation of epithelial stress responses. Uric acid exposure was associated with altered eIF2α signaling and reduced expression of the tight-junction protein ZO-1, indicating impaired epithelial barrier integrity. In the Transwell co-culture system, macrophages exposed to uric acid-stimulated epithelial signaling showed increased secretion of pro-inflammatory cytokines. Conclusion: Persistent airway uric acid may act as a compartment-specific metabolic stressor in COPD, altering epithelial translational stress signaling and barrier-associated ZO-1 expression while promoting macrophage inflammatory activation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.